Emiko Murayama

Title: Emiko Murayama: Innovator in Pharmaceutical Composition

Introduction

Emiko Murayama is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of modified release compositions. With a total of five patents to her name, her work has had a notable impact on drug delivery systems.

Latest Patents

Among her latest patents is a pharmaceutical composition for modified release that includes (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide or a pharmaceutically acceptable salt thereof. This composition is designed for sustained release, ensuring that the maximum blood drug concentration (Cmax) when administered in a fasted state is 400 ng/ml or less. Another patent focuses on a similar pharmaceutical composition that comprises specific additives to enhance water penetration and a hydrogel-forming polymer with a high average molecular weight.

Career Highlights

Emiko has worked with notable companies in the pharmaceutical industry, including Astellas Pharma GmbH and Ambit Biosciences Corporation. Her experience in these organizations has allowed her to refine her expertise in drug formulation and development.

Collaborations

Throughout her career, Emiko has collaborated with talented individuals such as Yuuki Takaishi and Yutaka Takahashi. These partnerships have contributed to her innovative work in the pharmaceutical sector.

Conclusion

Emiko Murayama's contributions to pharmaceutical compositions demonstrate her commitment to advancing drug delivery systems. Her innovative patents and collaborations highlight her role as a leading inventor in her field.